Pancreatic failure
RecruitingNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
- Disease:Pancreatic failure
- Substances:AmylaseLIPASE+2
Italy- Participants:18–64 years · 65+ years
- Substances:Amylase
Rare diseases
Investigational molecules
Locations
Viale Azeglio Ciampi Snc, 95121 Catania, Italy
Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania in Catania, Italy specialises in clinical trials of conditions such as Pancreatic failure, Systemic scleroderma, Interstitial lung disease, and other specialisations. This site conducts important research.
The department focuses on systemic sclerosis-associated interstitial lung disease, aiming to assess new treatments that may slow lung function decline and improve quality of life.
Research at the Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania supports advances in managing this rare connective‑tissue disorder.
Studies target exocrine pancreatic insufficiency, investigating the safety of novel lipase formulations to enhance digestive enzyme replacement.
The site’s work contributes to better nutritional support for patients with pancreatic enzyme deficits.
Clinical trials currently enrolling participants at this site.
Italy
ItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.